How are HAE strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the HAE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,695.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a HAE strangle?

The breakeven for the HAE strangle priced on this page is roughly $53.05 and $96.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HAE market-implied 1-standard-deviation expected move is approximately 10.69%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current HAE implied volatility affect this strangle?

HAE ATM IV is at 37.30% with IV rank near 5.04%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

HAE Strangle Strategy

HAE (Haemonetics Corporation), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.

Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions.

HAE (Haemonetics Corporation) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $3.51B, a trailing P/E of 36.71, a beta of 0.54 versus the broader market, a 52-week range of 47.32-87.32, average daily share volume of 882K, a public-listing history dating back to 1991, approximately 4K full-time employees. These structural characteristics shape how HAE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.54 indicates HAE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 36.71 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a strangle on HAE?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current HAE snapshot

As of June 29, 2026, spot at $76.14, ATM IV 37.30%, IV rank 5.04%, expected move 10.69%. The strangle on HAE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 200-day expiry.

Why this strangle structure on HAE specifically: HAE IV at 37.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a HAE strangle, with a market-implied 1-standard-deviation move of approximately 10.69% (roughly $8.14 on the underlying). The 200-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HAE expiries trade a higher absolute premium for lower per-day decay. Position sizing on HAE should anchor to the underlying notional of $76.14 per share and to the trader's directional view on HAE stock.

HAE strangle setup

The HAE strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HAE near $76.14, the first option leg uses a $80.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HAE chain at a 200-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HAE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$80.00	$10.25
Buy 1	Put	$70.00	$6.70

HAE strangle risk and reward

Net Premium / Debit: -$1,695.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$1,695.00
Breakeven(s): $53.05, $96.95
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

HAE strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on HAE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$5,304.00
$16.84	-77.9%	+$3,620.61
$33.68	-55.8%	+$1,937.23
$50.51	-33.7%	+$253.84
$67.35	-11.6%	-$1,429.55
$84.18	+10.6%	-$1,277.07
$101.01	+32.7%	+$406.32
$117.85	+54.8%	+$2,089.71
$134.68	+76.9%	+$3,773.10
$151.51	+99.0%	+$5,456.48

When traders use strangle on HAE

Strangles on HAE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HAE chain.

HAE thesis for this strangle

The market-implied 1-standard-deviation range for HAE extends from approximately $68.00 on the downside to $84.28 on the upside. A HAE long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current HAE IV rank near 5.04% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on HAE at 37.30%. As a Healthcare name, HAE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HAE-specific events.

HAE strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HAE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HAE alongside the broader basket even when HAE-specific fundamentals are unchanged. Always rebuild the position from current HAE chain quotes before placing a trade.

Frequently asked questions

What is a strangle on HAE?: A strangle on HAE is the strangle strategy applied to HAE (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With HAE stock trading near $76.14, the strikes shown on this page are snapped to the nearest listed HAE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are HAE strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the HAE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,695.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a HAE strangle?: The breakeven for the HAE strangle priced on this page is roughly $53.05 and $96.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HAE market-implied 1-standard-deviation expected move is approximately 10.69%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on HAE?: Strangles on HAE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HAE chain.
How does current HAE implied volatility affect this strangle?: HAE ATM IV is at 37.30% with IV rank near 5.04%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.